EQRx
Cambridge, MA
EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. Headquartered in Cambridge, Massachusetts, the company is backed by GV, ARCH Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, Nextech, and Arboretum Ventures.
https://www.eqrx.com/Company Details
Founded
- 2019
Employees
- Between 100 - 500 employees
Raised
- $1,900,000,000
Headquarters Location
- Cambridge, MA
Public
- Yes
Acquired
- Yes
Company Collections
These are collections EQRx is a part of. Click on the collection name to view similar companies.
EQRx's Investors
EQRx's Industries
Company Collections For EQRx
EQRx Headquarters Location
Total Amount Raised: $1,900,000,000
EQRx's Investors
EQRx Funding Rounds
Post Ipo Equity
$1,200,000,000
Post Ipo Equity Investors
SB Life ScienceAvidity PartnersVerilyRock Springs CapitalCasdin CapitalFidelityAndreessen HorowitzBVF PartnersMubadala Capital VenturesCorvexMubadalaInvusBoxer CapitalFranklin Resources, Inc.Bain Capital Life SciencesSeries B
$500,000,000
Series B Investors
Arch Venture PartnersAndreessen HorowitzGVArboretum VenturesNextech InvestS32Casdin CapitalBain Capital Life SciencesIPO
Unknown
Series A
$200,000,000
Series A Investors
GVNextech InvestAndreessen HorowitzArboretum VenturesArch Venture PartnersCasdin CapitalS32Bain Capital Life SciencesExor
EQRx Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on EQRx.